Rottinghaus Scott T. bought ENTA
February 12, 2024 · Form 4 insider transaction
Rottinghaus Scott T. bought 2,576 shares of Enanta Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,576
Price
$0.00
Total value
N/A
InsiderRottinghaus Scott T.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2024
Filing dateFebruary 14, 2024
Shares owned after29,042
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of Enanta common stock issued under performance share units ("PSUs") that vested as a result of performance against two-year research and development milestones in the calendar 2022-2023 period as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2024.